Dr. Hagop Kantarjian

 ''Hagop Kantarjian, MD serves as Clinical Consultant of Astex Therapeutics Limited. Dr. Kantarjian serves as the Chairman of the Leukemia Department and a Professor of Medicine of the University of Texas, MD Anderson Cancer Center. He has been associated with MD Anderson Cancer Center since 1981. Dr. Kantarjian is a leading expert in the field of chronic and acute leukemia and was a key investigator in clinical trials that led to the approval of Gleevec as a treatment ...''
Extract of Bloomberg Businessweek

How I treat newly diagnosed chronic phase CML
August 16, 2012, Journal Blood

Front-Line Therapy for CML (diaporama)
April 2012, First ME Hematology forum

         
ASH 2010 Acute Leukemia Hagop Kantarjian, MD, PhD The University of Texas              Video
December 2010, Oncology Tube

Newer Drugs Improve Upon Gleevec for Chronic Myeloid Leukemia                       Video
June 4, 2010, mdandersonorg